Skip to main content

US ClosedU.S. Closed

NCEL: NewcelX Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

NewcelX Ltd. , a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions.

52W Range

6thpctl

Volume

0.27×avg

Market Cap

1.44MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

NewcelX Ltd.

NCELNASDAQ Capital Market·USD·Closed

NewcelX Ltd.

NCELNASDAQ·USD·Closed

$3.19

−6.73%

$3.19

−$0.23 (6.73%)

52W Range

6thpctl

Volume

0.27×avg

Mkt Cap

1.44MUSD

P/E

-0.3TTM

Div Yield

–ann